Form 4: Core Scientific Director Receives RSU Grant

Core Scientific director Yadin Rozov was granted 18,575 restricted stock units, vesting in February 2027.

Summary

• Yadin Rozov, a Director of Core Scientific, Inc. (CORZ), received a grant of 18,575 restricted stock units (RSUs).
• The RSUs were granted on February 4, 2026, at a price of $0 per unit.
• These RSUs will vest in full on February 3, 2027.
• Vesting is contingent upon Mr. Rozov's continued service as a non-employee director of the Issuer on the vesting date.
• Following this transaction, Mr. Rozov beneficially owns 454,162 shares of Common Stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine director compensation and alignment of interests, without significant new financial or operational information.

Positives

• The RSU grant aligns the director's interests with long-term shareholder value through future vesting.
• It incentivizes continued service of a non-employee director, ensuring stability in corporate governance.

Risks

• The primary risk is that the RSUs will not vest if the director ceases to provide service to the Issuer before February 3, 2027.
• The value of the vested shares is subject to the future market price of Core Scientific, Inc. common stock.

Future Outlook

The grant of restricted stock units with a future vesting date of February 3, 2027, indicates an expectation of continued service from the non-employee director and aligns their incentives with the company's long-term performance.

Management Comments

• Represents a restricted stock unit ("RSU") grant. The RSUs will vest in full on February 3, 2027, provided that the Reporting Person continues to provide service to the Issuer as a non-employee director on such date.

Industry Context

StockSavvy.ai notes that equity grants, such as restricted stock units, are a common form of compensation for non-employee directors in the technology and cryptocurrency mining sectors. This practice is designed to align the interests of directors with those of shareholders by tying a portion of their compensation to the company's stock performance and ensuring their continued commitment.

Comparison to Industry Standards

• This RSU grant is consistent with standard compensation practices for non-employee directors in publicly traded companies, particularly within the technology and digital asset industries.
• Companies like Marathon Digital Holdings (MARA) and Riot Platforms (RIOT), also in the Bitcoin mining sector, frequently utilize similar equity-based compensation structures to incentivize and retain key personnel and directors.

Stakeholder Impact

• Shareholders: The grant aligns the director's long-term interests with shareholder value, potentially fostering more committed oversight.
• Employees: No direct impact on general employees is indicated.
• Directors: Reinforces the compensation structure for non-employee directors.

Next Steps

• Yadin Rozov's continued service as a non-employee director until February 3, 2027, for the RSUs to vest.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to an existing director, which is a standard compensation practice. It does not contain information that would fundamentally alter the investment thesis for Core Scientific, Inc., thus a 'hold' recommendation is appropriate as it neither signals significant positive nor negative operational or financial changes.

Keywords

Core Scientific, CORZ, Yadin Rozov, Restricted Stock Units, RSU, Director Compensation, SEC Form 4, Equity Grant, Beneficial Ownership